Aker BioMarine ASA (OSL:AKBM)

Norway · Delayed Price · Currency is NOK

97.20

-1.50 (-1.52%)

Jan 2, 2026, 4:25 PM CET

44.86% (1Y)

Market Cap	8.66B
Revenue (ttm)	2.14B
Net Income (ttm)	-365.56M
Shares Out	87.70M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	39.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,507
Average Volume	22,587
Open	95.50
Previous Close	98.70
Day's Range	95.00 - 97.90
52-Week Range	43.65 - 99.00
Beta	0.36
RSI	76.57
Earnings Date	Feb 12, 2026

About Aker BioMarine ASA

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. ... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2006

Employees 249

Stock Exchange Oslo Børs

Ticker Symbol AKBM

Full Company Profile